טוען...
Optimal two-stage design of single arm Phase II clinical trials based on median event time test
The Phase II clinical trials aim to assess the therapeutic efficacy of a new drug. The therapeutic efficacy has been often quantified by response rate such as overall response rate or survival probability in the Phase II setting. However, there is a strong desire to use survival time, which is the g...
שמור ב:
| הוצא לאור ב: | PLoS One |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7870013/ https://ncbi.nlm.nih.gov/pubmed/33556130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0246448 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|